BioCentury
ARTICLE | Company News

Durect, Mallinckrodt deal

April 2, 2001 7:00 AM UTC

MKG will supply sufentanil opioid anesthetic for DRXX's clinical and commercial needs. DRRX's Duros sufentanil sustained release osmotic delivery product is in Phase II testing. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article